CoChat
Sign Up
Cited by 53Psychopathy, Forensic Psychiatry, Sexual OffendingHealth Systems, Economic Evaluations, Quality of LifeNeurotransmitter Receptor Influence on Behavior

Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders

Open access
Adi, Y, Ashcroft, D, Browne, K, Beech, A, Fry-Smith, A, Hyde, C·2002·Health Technology Assessment
DOI 10.3310/hta6280
Open this paper in CoChat — free accountOpen PDF

Abstract

Technical terms and abbreviations are used throughout this report.The meaning is usually clear from the context, but a glossary is provided for the non-specialist reader.In some cases, usage differs in the literature, but the term has a constant meaning throughout this review.Attrition bias Systematic differences between comparison groups in withdrawals or exclusions of participants from the results of a study.For example, patients may drop out of a study because of side-effects of the intervention.Excluding these patients from the analysis could result in an over-estimate of the effectiveness of the intervention. Detection bias (ascertainment bias)Systematic differences between comparison groups in how outcomes are ascertained, diagnosed or verified.Exhibitionism A disorder in which fantasies about or the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger. Fetishism (psychiatric)A condition in which inanimate objects are utilised as a preferred or exclusive method of stimulating erotic arousal.Frotteurism Behaviour that involves touching and rubbing against a non-consenting person.This usually occurs in crowded places where the individual can more easily escape arrest.Heterogeneity Variability or differences between studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3310/hta6280

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adi 2002 reviewed the clinical effectiveness and cost-consequences of SSRIs in the treatment of sex offenders but identified no RCTs and only nine case series studies with a total of 225 participants.

    “Adi 2002 reviewed the clinical effectiveness and cost-consequences of SSRIs in the treatment of sex offenders but identified no RCTs and only nine case series studies with a total of 225 participants.”

    From Pharmacological interventions for those who have sexually offended or are at risk of offending (2015) · cites this paper as Adi 2002

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 60 references couldn’t be matched to a known paper.

Research works printed but not linked: 28

  1. Soothill K, Walby S. Sex crime in the news. London: Routledge; 1991.
  2. White P, Bradley C, Ferriter M, Hatzipetrou L. Managements for people with disorders of sexual preference and for convicted sexual offenders (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software; 2000.
  3. Home Office. A review of classification systems for sex offenders. London: Home Office; 1998. Report No.: Home Office research findings 78.
  4. McCann IL, Sakheim DK, Abrahamson DJ. Trauma and victimisation: a model of psychological adapt- ation. The Counselling Psychologist 1998;16:531-94.
  5. National Statistics Office. Cautions, court proceedings and sentencing, England and Wales, 2000. London: National Statistics Office; 2000.
  6. Creighton S. Recognising changes in incidence and prevalence. In: Browne K, Hanks H, Stratton P, Hamilton C, editors. Early prediction and pre- vention of child abuse: a handbook. Chichester: John Wiley & Sons; 2002.
  7. Beech A, Fordham A. Therapeutic climate of sexual offender treatment programmes. Sexual Abuse: J Res Treatment 1997;9:219-37.
  8. Hanson RK, Thornton D. Improving risk assess- ments for sexual offenders: a comparison of three actuarial scales. Law Hum Behav 2000;24:119-36.
  9. Hall GC. Sex offender recidivism revisited: a meta- analysis of recent treatment studies. J Consulting Clin Psychol 1995;63:802-9.
  10. Bradford JM. The antiandrogen and hormonal treatment of sex offenders. In: Marshall WL, Barbaree HE, editors. Handbook of sexual assault: issues, theories and treatment of the offenders. New York: Plenum Press; 1990. p. 297-310.
  11. Langevin R. Sexual anomalies in the brain. In: Marshall WL, Barbaree HE, editors. Handbook of sexual assault: issues, theories and treatment of the offenders. New York: Plenum Press; 1990. p. 103-13.
  12. Tork I. Anatomy of the serotonergic system. In: Peroutka S, Whitaker-Azmitia P, editors. Neuro- pharmacology of serotonin. New York: Annals of the New York Academy of Science; 1990. p. 9-35.
  13. Bradford JMW. The paraphilias, obsessive com- pulsive spectrum disorder and the treatment of sexually deviant behaviour. Psychiatr Q 1999;70:209-19.
  14. Lorrain D, Riolo J, Matuszewich L, Hull E. Lateral hypothalamic serotonin inhibits nucleas accumbens dopamine: implications for sexual satiety. J Neurosci 1999;19:7648-52.
  15. Kafka MP. The role of medications in the treatment of paraphilia-related disorders: psychopharmaco- logical treatments for non-paraphilic compulsive sexual behaviors: a review. Sexual Relationship Ther 2001;16:105-12.
  16. Kuzel R. Management of depression. Current trends in primary care. Postgrad Med 185;99:179-80.
  17. Marshall WL, Barbaree HE. Outcome of comprehensive cognitive-behavioural treatment programs. In: Marshall WL, Laws DR, Barbaree HE, editors. Handbook of sexual assault: issues, theories, and treatment of the offender. New York: Plenum Press; 1990. p. 363-85.
  18. Morrison T, Erooga M, Beckett RL. Adult sex offenders: who are they? Why and how do they do it? Sexual offending against children: assess- ment and treatment of male abusers. London: Routledge; 1994. p. 1-24.
  19. Barbaree H. Evaluating treatment efficacy with sexual offenders. Sexual Abuse: J Res Treatment 1997;9:111-29.
  20. Cochrane reviewers handbook. 4.1.4 ed. Oxford: Update Software; 2001.
  21. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness. CRD's guidance for those carrying out or commissioning reviews. CRD Report No. 4 (second edition). York: University of York; 2001.
  22. Fedoroff JP. Antiandrogens vs serotonergic medications in the treatment of sex offenders: a preliminary compliance study. Can J Hum Sexuality 1995;4:111-23.
  23. Kafka M, Hennen J. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia- related disorders: a case series. J Clin Psychiatry 2000;61:664-70.
  24. Donato R, Shanahan M. The economics of child sex offender rehabilitation programs: beyond Prentky & Burgess. Am J Orthopsychiatry 2001;71:131-9.
  25. Shanahan M, Donato R. Counting the cost: estimating the economic benefit of paedophile treatment programs. Child Abuse Neglect 2001;25:541-55.
  26. Serotonin in various psychiatric diseases: depression, neurosis and sexual deviation. Therapiewoche 1992;42:274-5.
  27. Becker JV. Sexual deviance. Curr Opin Psychiatry 1992;5:788-91.
  28. Duggan C. Sexual crime. Curr Opin Psychiatry 1998;11:663-7.

Cited by

Sorted by citations

Related

Authors
Adi, Y., Ashcroft, D., Browne, K., Beech, A., Fry-Smith, A., & Hyde, C.
Affiliations
University of Birmingham (GB)
ORCID
Venue
Health Technology Assessment
Publisher
National Institute for Health and Care Research
Published
2002-11
Volume
6
Issue
28
Pages
1-66
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
DOI
10.3310/hta6280
OpenAlex
W2396186431
Cited by
52
References
60
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 2
FWCI
0.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
Health Technology Assessment programme (01/30/01)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
selective serotonin reuptake inhibitors, sexual offenders, recidivism, cost-effectiveness, offender treatment, psychopharmacological treatment
MeSH terms
Androgen Antagonists, Cost-Benefit Analysis, Female, Humans, Male, Sex Offenses, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Cyproterone Acetate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review